Filing Details
- Accession Number:
- 0000950170-25-040455
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-17 17:01:47
- Reporting Period:
- 2025-03-13
- Filing Date:
- 2025-03-17
- Accepted Time:
- 2025-03-17 17:01:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1605456 | K Vivek Jayaraman | C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520 | Chief Operating Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-03-13 | 29,985 | $1.45 | 1,477,330 | No | 4 | S | Direct | |
Common Stock | Disposition | 2025-03-14 | 46,004 | $1.45 | 1,431,326 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person.
- Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.47 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.39 to $1.45 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.